Fresh bribery claims hit Glaxo

UK-BASED pharmaceuticals giant Glaxosmithkline has been hit by another set of allegations over bribery, admitting yesterday that it is investigating the actions of some staff in Lebanon and Jordan.

“We are investigating allegations regarding the activity of a small number of individuals in our operations in Jordan and Lebanon,” it said in a statement yesterday. It said it started investigations, using internal and external teams, as soon as it became aware of the claims.

Add a Comment

In Other News